Prevention of a first stroke - A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association

被引:346
作者
Gorelick, PB
Sacco, RL
Smith, DB
Alberts, M
Mustone-Alexander, L
Rader, D
Ross, JL
Raps, E
Ozer, MN
Brass, LM
Malone, ME
Goldberg, S
Booss, J
Hanley, DF
Toole, JF
Greewold, NL
Rhew, DC
机构
[1] NPS, Salt Lake City, UT USA
[2] Searle & Lorex Pharmaceut, Skokie, IL USA
[3] Cedars Sinai Hlth Syst, Zynx Hlth, Beverly Hills, CA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 12期
关键词
D O I
10.1001/jama.281.12.1112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To establish, in a single resource, up-to-date recommendations for primary care physicians regarding prevention strategies for a first stroke. Participants Members of the National Stroke Association's (NSA's) Stroke Prevention Advisory Board and Cedars-Sinai Health System Department of Health Services Research convened on April 9, 1998, in an open meeting. The conference attendees, selected to participate by the NSA, were recognized experts in neurology (9), cardiology (2), family practice (1), nursing (1), physician assistant practices (1), and health services research (2). Evidence A literature review was carried out by the Department of Health Services Research, Cedars-Sinai Health System, Los Angeles, Calif, using the MEDLINE database search for 1990 through April 1998 and updated in November 1998. English-language guidelines, statements, meta-analyses, and overviews on prevention of a first stroke were reviewed. Consensus Process At the meeting, members of the advisory board identified 6 important stroke risk factors (hypertension, myocardial infarction [MI], atrial fibrillation, diabetes mellitus, blood lipids, asymptomatic carotid artery stenosis), and 4 lifestyle factors (cigarette smoking, alcohol use, physical activity, diet). Conclusions Several interventions that modify well-documented and treatable cardiovascular and cerebrovascular risk factors can reduce the risk of a first stroke. Good evidence for direct stroke reduction exists for hypertension treatment; using warfarin for patients after MI who have atrial fibrillation, decreased left ventricular ejection fraction, or left ventricular thrombus; using 3-hydroxy3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors for patients after MI; using warfarin for patients with atrial fibrillation and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at least 60%. Observational studies support the role of modifying lifestyle-related risk factors leg, smoking, alcohol use, physical activity, diet) in stroke prevention. Measures to help patients improve adherence are an important component of-a stroke prevention plan.
引用
收藏
页码:1112 / 1120
页数:9
相关论文
共 127 条
  • [1] *4 AM COLL CHEST P, 1995, CHEST S, V108, pS225
  • [2] RISK OF STROKE IN MALE CIGARETTE SMOKERS
    ABBOTT, RD
    YIN, Y
    REED, DM
    YANO, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) : 717 - 720
  • [3] Antithrombotic and thrombolytic therapy for ischemic stroke
    Albers, GW
    Easton, JD
    Sacco, RL
    Teal, P
    [J]. CHEST, 1998, 114 (05) : 683S - 698S
  • [4] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [5] [Anonymous], 1996, JAMA, V276, P241
  • [6] [Anonymous], 1991, JAMA, V265, P3255
  • [7] [Anonymous], 1997, Arch Intern Med, V157, P1237
  • [8] [Anonymous], DIABETES CARE
  • [9] [Anonymous], 1994, CANADIAN GUIDE CLIN
  • [10] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]